Vertex Pharmaceuticals (VRTX) Fails to deliver data

Key failure to deliver metrics for Vertex Pharmaceuticals:

• Last SEC data release: 2025-02-28
• Last 15 days FTD volume: S$3.14 M
• Last 3 months FTD volume: S$17.96 M
• Last year FTD volume: S$17.96 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Vertex Pharmaceuticals (VRTX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Vertex Pharmaceuticals (VRTX) - since 2013

Vertex Pharmaceuticals (VRTX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	S$11.91 M	S$97.11 M	🇺🇸 USA
AbbVie ABBV	S$45.77 M	S$0.20 B	🇺🇸 USA
Merck MRK	S$0.10 B	S$0.17 B	🇺🇸 USA
Bristol-Myers Squibb BMY	S$0.17 B	S$0.49 B	🇺🇸 USA
Johnson & Johnson JNJ	S$17.52 M	S$0.22 B	🇺🇸 USA
Enanta Pharmaceuticals ENTA	S$0.22 M	S$1.05 M	🇺🇸 USA